RecruitingNCT05558371
International CDKL5 Clinical Research Network
Studying CDKL5-deficiency disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Principal Investigator
- Timothy A Benke, MD PhD, MDUniversity of Colorado, Denver
- Intervention
- No intervention.(other)
- Enrollment
- 1000 enrolled
- Eligibility
- 100 years · All sexes
- Timeline
- 2021 – 2027
Study locations (9)
- University of California Los Angeles/UCLA Mattel Children's Hospital, Los Angeles, California, United States
- University of Colorado Denver/Children's Hospital Colorado, Aurora, Colorado, United States
- Harvard Medical School/Boston Children's Hospital, Boston, Massachusetts, United States
- Washington University in St. Louis/St. Louis Children's Hospital, St Louis, Missouri, United States
- NYU Langone Health, New York, New York, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Baylor College of Medicine/ Texas Children's Hospital, Houston, Texas, United States
- Telethon Kids Institute/Perth Children's Hospital, Perth, Nedlands Western Australia, Australia
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS) · National Institutes of Health (NIH) · International Foundation for CDKL5 Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05558371 on ClinicalTrials.govOther trials for CDKL5-deficiency disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06448663Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD)University of Milan
- ACTIVE NOT RECRUITINGNCT05373719Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency DisorderLoulou Foundation
- ACTIVE NOT RECRUITINGPHASE3NCT05064878A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency DisorderZogenix, Inc.